Baba Shinji, Oji Yuto, Teramoto Makoto, Kawabata Kazuya, Saito Atsuo
Dept. of Surgery, Shinkawabata Hospital.
Gan To Kagaku Ryoho. 2009 Nov;36(11):1905-6.
A 44-year-old female with premenopausal advanced breast cancer had been treated with a combination of LH-RH analogue and tamoxifen as primary endocrine therapy following adjuvant chemotherapy. Forty-seven months after operation, because metastases of contralateral axillary lymph nodes were detected by computer tomography, she was treated with a combination of LH-RH analogue and aromatase inhibitor as second-line endocrine therapy. During the 16-month administration of LH-RH analogue and aromatase inhibitor, she was been well without new metastatic lesions and maintained a high quality of life.
一名44岁绝经前晚期乳腺癌女性患者，在辅助化疗后接受促性腺激素释放激素（LH-RH）类似物和他莫昔芬联合治疗作为一线内分泌治疗。术后47个月，因计算机断层扫描检测到对侧腋窝淋巴结转移，她接受LH-RH类似物和芳香化酶抑制剂联合治疗作为二线内分泌治疗。在LH-RH类似物和芳香化酶抑制剂治疗的16个月期间，她病情良好，无新的转移病灶，生活质量得以维持。
